Summit Therapeutics Inc.

NASDAQ: SMMT · Real-Time Price · USD
23.84
0.75 (3.25%)
At close: May 16, 2025, 3:59 PM
23.55
-1.24%
Pre-market: May 19, 2025, 04:11 AM EDT
3.25%
Bid 23.17
Market Cap 17.59B
Revenue (ttm) n/a
Net Income (ttm) -240.75M
EPS (ttm) -0.34
PE Ratio (ttm) -70.13
Forward PE -47.04
Analyst Buy
Ask 23.88
Volume 1,341,660
Avg. Volume (20D) 4,065,237
Open 23.42
Previous Close 23.09
Day's Range 23.05 - 23.94
52-Week Range 2.10 - 36.91
Beta -0.95

About SMMT

undefined

Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol SMMT
Website n/a
Full Company Profile

Analyst Forecast

According to 0 analyst ratings, the average rating for SMMT stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

Stock Forecasts
3 weeks ago
-36.05%
Summit Therapeutics shares are trading lower. The ... Unlock content with Pro Subscription
3 weeks ago
+21.5%
Summit Therapeutics shares are trading higher after the company provided updates on its Phase 3 trial of Ivonescimab and announced it met its primary endpoint.